Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Families and children news

Show

From To
Poor weight gain during first year of ART associated with increased mortality risk for children with HIV in resource-limited settings

Poor weight gain after starting antiretroviral therapy (ART) is associated with increased mortality risk for children with HIV, investigators report in the online edition of AIDS. An international team

Published
09 December 2014
By
Michael Carter
I’m living with HIV, but it doesn’t define me

When I was 13, my doctor sat me down and told me that I was HIV-positive. Sitting next to me, my mum was silent, in denial of the virus that she had unknowingly passed to me.

Published
07 December 2014
From
The Guardian
Conceiving a Child on Truvada as PrEP Appears Safe

Taking Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) until shortly after conception of a child appears safe.

Published
03 December 2014
From
POZ
UNICEF: 1.1 million HIV infections in children averted

An estimated 1.1 million HIV infections among children under 15 have been averted, as new cases declined by over 50 per cent between 2005 and 2013, according to data released by UNICEF today ahead of World AIDS Day.

Published
02 December 2014
From
UNICEF
The Medicines Patent Pool (MPP) Signs Licensing Agreement with AbbVie for HIV Paediatric Formulations of Lopinavir and Ritonavir

he licence will enable other companies and organisations to re-formulate and manufacture specially designed LPV/r and r paediatric treatments for distribution in low- and middle-income countries where 99% of children with HIV in the developing world live.

Published
02 December 2014
From
Medicines Patent Pool
How PrEP Helped One HIV-Negative Woman Become a Mother

All Poppy Morgan of San Francisco wanted was to see her husband, Ted, reflected in their child's face. Unfortunately, for many years, this could not be a reality. Ted was HIV positive, and Poppy could not find a way to conceive safely. After many disappointments, including a brief hope for sperm washing that was quickly dashed, Poppy found pre-exposure prophylaxis (PrEP).

Published
26 November 2014
From
The Body
AIDS is No. 1 Killer of African Teenagers

HIV among teenagers is devastating families in Nigeria and elsewhere in Africa, where AIDS has become the leading cause of death among adolescents. One reason for this shocking teen death toll is the low number of adolescents on antiretroviral treatment (ART).

Published
25 November 2014
From
Inter Press Service
NNRTI + 3 NRTIs may be strong first regimen in UK/Ireland children

Children starting antiretroviral therapy (ART) with a nonnucleoside (NNRTI) plus 3 nucleosides (NRTIs) had the lowest 2-year virologic failure rate in a study of 997 children in the United Kingdom and Ireland. Five-year toxicity rates were similar with the NNRTI and protease inhibitor (PI) regimens studied.

Published
24 November 2014
From
International AIDS Society
NIH-sponsored study identifies superior drug regimen for preventing mother-to-child HIV transmission

For HIV-infected women in good immune health, taking a three-drug regimen during pregnancy prevents mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor and two more after giving birth, an international clinical trial has found. The ongoing PROMISE (Promoting Maternal-Infant Survival Everywhere) study also has found that one triple-drug regimen for preventing mother-to-child transmission may be safer than another for women and their babies.

Published
18 November 2014
From
National Institutes of Health press release
NIH Trial Tests Very Early Anti-HIV Therapy in HIV-Infected Newborns

​A new clinical trial is exploring whether giving anti-HIV therapy soon after birth to infants who became infected with HIV in the womb leads to remission of the virus, enabling the children eventually to stop treatment for an extended time period. The trial aims to build on the case of the 'Mississippi Baby'.

Published
05 November 2014
From
National Institute of Allergy and Infectious Diseases (NIAID) press release

Filter by country